Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank Entschladen

Showing results (11-20 of 56) with videos related to

Pageof 6
Sort By:
Seminars in Cancer Biology|February 6, 2008
The cancer's nervous tooth: Considering the neuronal crosstalk within tumorsFrank Entschladen, Daniel Palm, Bernd Niggemann, et al.
Journal of Periodontology|September 3, 2009
Influence of enamel matrix derivative on primary CD4+ T-helper lymphocyte migration, CD25 activation, and apoptosisGeorg Gassmann, Bettina Schwenk, Frank Entschladen, et al.
International Journal of Cancer|July 13, 2002
Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loopKerstin Lang, Bernd Niggemann, Kurt S Zanker, et al.
Cancer Research|November 20, 2002
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cellsJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2006
Tumor immune escape mechanisms: impact of the neuroendocrine systemKerstin Lang, Frank Entschladen, Corinna Weidt, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.
Cell Communication and Signaling : CCS|July 15, 2010
PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironmentMelanie J Voss, Bernd Niggemann, Kurt S Zänker, et al.
Current Pharmaceutical Design|October 25, 2014
Anti-metastatics: an overview of drug candidates in current pipelinesAnne Schaap-Nutt, Dane A Thyssen, David W Drell, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Inhibition of cell migration via G protein-coupled receptors to opioid peptides and angiotensinFrank Entschladen, Philipp Bastian, Bernd Niggemann, et al.
Seminars in Cancer Biology|August 2, 2005
In vitro and in vivo imaging of cell migration: two interdepending methods to unravel metastasis formationDaniel Palm, Kerstin Lang, Burkhard Brandt, et al.
Pageof 6

Showing results (11-20 of 56) with videos related to

Sort By:
Pageof 6
Seminars in Cancer Biology|February 6, 2008
The cancer's nervous tooth: Considering the neuronal crosstalk within tumorsFrank Entschladen, Daniel Palm, Bernd Niggemann, et al.
Journal of Periodontology|September 3, 2009
Influence of enamel matrix derivative on primary CD4+ T-helper lymphocyte migration, CD25 activation, and apoptosisGeorg Gassmann, Bettina Schwenk, Frank Entschladen, et al.
International Journal of Cancer|July 13, 2002
Signal processing in migrating T24 human bladder carcinoma cells: role of the autocrine interleukin-8 loopKerstin Lang, Bernd Niggemann, Kurt S Zanker, et al.
Cancer Research|November 20, 2002
The neurotransmitter gamma-aminobutyric acid is an inhibitory regulator for the migration of SW 480 colon carcinoma cellsJan Joseph, Bernd Niggemann, Kurt S Zaenker, et al.
Cancer Immunology, Immunotherapy : CII|January 26, 2006
Tumor immune escape mechanisms: impact of the neuroendocrine systemKerstin Lang, Frank Entschladen, Corinna Weidt, et al.
Recent Patents on Anti-Cancer Drug Discovery|January 29, 2008
Inhibitors for metastasis developmentKerstin Lang, Theodore L Drell, Kurt S Zaenker, et al.
Cell Communication and Signaling : CCS|July 15, 2010
PC-3 prostate carcinoma cells release signal substances that influence the migratory activity of cells in the tumor's microenvironmentMelanie J Voss, Bernd Niggemann, Kurt S Zänker, et al.
Current Pharmaceutical Design|October 25, 2014
Anti-metastatics: an overview of drug candidates in current pipelinesAnne Schaap-Nutt, Dane A Thyssen, David W Drell, et al.
Annals of the New York Academy of Sciences|January 15, 2005
Inhibition of cell migration via G protein-coupled receptors to opioid peptides and angiotensinFrank Entschladen, Philipp Bastian, Bernd Niggemann, et al.
Seminars in Cancer Biology|August 2, 2005
In vitro and in vivo imaging of cell migration: two interdepending methods to unravel metastasis formationDaniel Palm, Kerstin Lang, Burkhard Brandt, et al.
Pageof 6